Exelixis, Inc.EXELNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank62
5Y CAGR-32.6%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
-32.6%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q1 202626.39%
Q4 20255.88%
Q3 202519.30%
Q2 202518.75%
Q4 202417.07%
Q3 2024-47.44%
Q2 2024550.00%
Q1 2024-57.14%
Q4 20238384.85%
Q3 2023-98.68%
Q2 2023108.33%
Q1 2023228.62%
Q4 2022-140.57%
Q3 20224.55%
Q3 20224.76%
Q2 2022-30.00%
Q4 2021150.00%
Q4 2021-61.29%
Q3 20215978.43%
Q2 2021-94.33%
Q4 2020190.00%
Q4 2020-145.45%
Q3 202037.50%
Q2 2020-30.43%
Q4 2019-28.13%
Q3 201923.08%
Q2 20194.00%
Q1 2019-79.17%
Q4 2018185.71%
Q3 201844.83%
Q2 2018-25.64%
Q1 2018200.00%
Q4 2017-53.57%
Q3 2017366.67%
Q2 20170.00%
Q1 2017-50.00%
Q4 2016372.73%
Q3 201672.50%
Q3 201640.74%
Q2 2016-42.11%